PARP inhibitor · small molecule
senaparib
0 active trials, targeting PARP. Not approved for any biomarker on marked.bio yet.
Also known as IMP4297, Sepalna.
Counts only trials that select patients by one of the biomarkers on marked.bio, not every trial of this drug.
Biomarkers
| Biomarker | Active trials | All trials | Furthest active phase |
|---|---|---|---|
| BRCA1/2 mutation | 0 | 1 | – |
Trials
0 of 1 trials shown
-
Study of IMP4297 in Patients With BRCA1/2 Mutation Ovarian Cancer
Germline and/or somatic BRCA1/2 mutation confirmed by central laboratory;
BRCA1/2 mutationOvarian Cancer
No trials match these filters.